Vildagliptin + Metformin Hydrochloride

Introduction

Diabetes mellitus, a chronic metabolic disorder, affects millions of people worldwide. It is characterized by elevated blood sugar levels resulting from either insufficient insulin production or the body's inability to use insulin effectively. The management of diabetes involves a combination of lifestyle changes, diet control, and pharmacological interventions. Among the most commonly prescribed medications for type 2 diabetes are Metformin and Vildagliptin, two medications that help control blood sugar levels through different mechanisms. Vildiabate M 1000, a combination of Metformin (1000 mg) SR (Sustained Release) and Vildagliptin (50 mg), is an innovative treatment that provides a more effective way to manage type 2 diabetes.

In this article, we will explore the key ingredients of Vildiabate M 1000, how they work together, their benefits, dosage guidelines, potential side effects, and the impact on overall diabetes management.

What Is Vildiabate M 1000?

Vildiabate M 1000 is a combination medication designed for the treatment of type 2 diabetes. It combines two active ingredients: Metformin and Vildagliptin. Both of these drugs play an important role in managing high blood sugar, but they operate through different mechanisms, providing a comprehensive approach to diabetes treatment.

• Metformin (1000 mg) SR: A biguanide that works by decreasing the amount of glucose produced by the liver and improving the body's sensitivity to insulin.
• Vildagliptin (50 mg): A DPP-4 (dipeptidyl peptidase-4) inhibitor that works by increasing insulin release in response to meals and reducing the amount of glucagon (a hormone that raises blood sugar levels) in the blood.

Key Ingredients and Their Mechanisms of Action

1. Metformin (1000 mg) SR
   Metformin is one of the first-line treatments for type 2 diabetes and has been used for decades. It works through several mechanisms:

   • Decreases hepatic glucose production: Metformin inhibits the production of glucose by the liver, which helps lower blood sugar levels.
   • Increases insulin sensitivity: By improving the sensitivity of muscle cells to insulin, Metformin allows for better glucose uptake from the bloodstream, helping to lower blood sugar.
   • Slows intestinal glucose absorption: Metformin also has a mild effect on slowing the absorption of glucose from the intestines, reducing postprandial (after meal) blood sugar spikes.

   The sustained-release formulation of Metformin in Vildiabate M 1000 helps in maintaining a more consistent blood concentration, reducing side effects like gastrointestinal discomfort, which is common with regular-release Metformin.

2. Vildagliptin (50 mg)
   Vildagliptin is an oral DPP-4 inhibitor that works by enhancing the effects of incretins, natural hormones that regulate insulin and glucagon levels in the body. Vildagliptin has several important actions:

   • Increases insulin secretion: It enhances insulin secretion in response to meals, particularly when blood sugar levels are elevated.
   • Reduces glucagon secretion: By inhibiting glucagon, Vildagliptin prevents the liver from producing too much glucose when blood sugar is already high.
   • Helps control postprandial blood sugar: This action is particularly beneficial in controlling blood sugar after meals, a crucial time when spikes in glucose levels are common in diabetics.

When used together, Metformin and Vildagliptin provide complementary actions, effectively lowering both fasting and postprandial blood glucose levels.

Uses of Vildiabate M 1000

Vildiabate M 1000 is prescribed for the treatment of type 2 diabetes mellitus in patients who cannot adequately control their blood sugar levels through diet, exercise, or a single medication. The combination of Metformin and Vildagliptin allows for more comprehensive blood sugar control.

• Blood sugar control: The dual action of Metformin and Vildagliptin provides a balanced approach to lowering blood glucose levels throughout the day.
• Better control of postprandial blood sugar: Vildagliptin’s action is especially helpful in controlling the rise in blood sugar that occurs after meals, a common challenge in managing diabetes.
• Improved insulin sensitivity: Metformin helps improve the body's response to insulin, making it easier for cells to absorb glucose from the bloodstream.

Vildiabate M 1000 is typically used in conjunction with other diabetes management strategies, such as dietary changes, physical activity, and weight management, to achieve optimal control of blood sugar levels.

Dosage of Vildiabate M 1000

The recommended dose of Vildiabate M 1000 depends on the patient's individual needs and the advice of their healthcare provider. However, the general guidelines are as follows:

• Starting dose: Most patients start with one tablet of Vildiabate M 1000 once daily, usually taken with food to minimize gastrointestinal side effects.
• Dosage adjustments: Depending on the patient's blood sugar control, the dose may be adjusted. In some cases, the dose may be increased to two tablets daily (one in the morning and one in the evening).
• Maximum dose: The maximum recommended dose of Vildiabate M 1000 is two tablets per day, which would provide a total of 2000 mg of Metformin SR and 100 mg of Vildagliptin.

It is crucial to follow the healthcare provider's instructions and adjust the dosage according to the patient’s individual response and blood sugar levels. Regular blood tests will help in monitoring the treatment's effectiveness.

Benefits of Vildiabate M 1000

Vildiabate M 1000 offers several significant benefits for individuals with type 2 diabetes:

1. Improved blood sugar control: The combination of Metformin and Vildagliptin helps to lower both fasting and postprandial glucose levels, contributing to better overall blood sugar management.
2. Convenience: By combining two effective medications in one tablet, Vildiabate M 1000 simplifies diabetes management, reducing the need for multiple medications and dosages.
3. Reduced risk of complications: Effective blood sugar control with Vildiabate M 1000 helps reduce the risk of long-term complications associated with diabetes, such as heart disease, kidney damage, and nerve damage.
4. Minimal weight gain: Unlike some other diabetes medications, Vildiabate M 1000 is less likely to cause significant weight gain, a common concern for many diabetics.
5. Lower risk of hypoglycemia: When used alone, Vildagliptin has a low risk of causing hypoglycemia (low blood sugar), especially when combined with Metformin, which does not tend to cause low blood sugar levels on its own.

Side Effects of Vildiabate M 1000

Like all medications, Vildiabate M 1000 may cause side effects. However, not everyone will experience them. The most common side effects are:

• Gastrointestinal issues: Metformin is known to cause side effects like nausea, diarrhea, and abdominal discomfort, especially when starting the medication. The sustained-release formulation in Vildiabate M 1000 helps reduce these effects.
• Headache: Some patients may experience mild headaches when using Vildiabate M 1000.
• Upper respiratory tract infections: Vildagliptin can sometimes cause infections such as a runny nose or sore throat.
• Low blood sugar (hypoglycemia): Although rare, the combination of Metformin and Vildagliptin can cause low blood sugar, particularly when taken with other diabetes medications that increase insulin production.
• Lactic acidosis: A rare but serious side effect of Metformin is lactic acidosis, a condition in which there is too much lactic acid in the blood. Symptoms include muscle pain, difficulty breathing, and dizziness. This condition requires immediate medical attention.

Patients should report any unusual or severe side effects to their healthcare provider.

Precautions and Interactions

Before starting Vildiabate M 1000, patients should inform their doctor of any existing medical conditions, such as kidney or liver disease, heart conditions, or a history of lactic acidosis. It is also essential to inform the doctor about any other medications the patient is taking, as Vildiabate M 1000 can interact with other drugs, including:

• Insulin and sulfonylureas: These drugs may increase the risk of hypoglycemia when used with Vildiabate M 1000.
• Corticosteroids and diuretics: These medications can interfere with blood sugar levels and require careful monitoring when combined with Vildiabate M 1000.

Conclusion

Vildiabate M 1000 is a powerful combination of Metformin (1000 mg) SR and Vildagliptin (50 mg) that provides an effective treatment for type 2 diabetes. The combination of these two medications offers a comprehensive approach to managing blood glucose levels by targeting different mechanisms in the body. With proper use, Vildiabate M 1000 can help improve blood sugar control, reduce the risk of complications, and enhance the overall quality of life for people with type 2 diabetes.

Patients should follow their healthcare provider's recommendations regarding dosage and regularly monitor their blood sugar levels to ensure the medication is working effectively. By incorporating Vildiabate M 1000 into a broader diabetes management plan that includes diet and exercise, individuals can achieve better control of their diabetes and live healthier lives.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW